Further analysis of the relationship between PRPF4 expression and survival rates in 152 patients with DLBC and AML revealed that high PRPF4 expression was significantly associated with lower survival rates compared to patients with low PRPF4 expression (Fig. S1B). This evidence concerns the gene PRPF4 and acute myeloid leukemia.